Daniel T. Lemaitre has served on the Globus Medical Board of Directors since April 2011 and is a member of the Board's Compensation Committee and Audit Committee. He brings extensive business, managerial, executive and leadership experience in the medical device industry.
Mr. Lemaitre previously served as the CEO of BlueWind Medical, a neuromodulation company based in Israel, from January 2020 until September 2024, after serving as its Executive Chairman from September 2018 until January 2020. He most recently served as President and Chief Executive Officer of Direct Flow Medical. Previously, he served as Chief Executive Officer of White Pine Medical, a venture-backed medical device start-up, from June 2009 until May 2015, and as President and CEO of CoreValve, a privately held company focused on percutaneous aortic valve replacement, from April 2008 until its acquisition by Medtronic PLC in April 2009.
From 2005 until March 2008, Mr. Lemaitre was a Senior Vice President at Medtronic, where he led the company's strategic planning and corporate development. Prior to Medtronic, he spent 28 years as an investment analyst in the medical device field, including 18 years with SG Cowen, where he was a managing director and led the healthcare research team, and six years with Merrill Lynch.
Mr. Lemaitre holds a B.A. in Economics from Bethany College and an M.B.A. from Bowling Green State University. He has previously served on numerous boards, including CoreValve, Direct Flow Medical, Inc., Mitralign Inc., Endologix, Inc. (Chair), Nitinol Development Corporation, and Bioventus Inc. (Chair).